Opening the Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble Contrast Agent

<table class="fixed-width table-group" id="tab2"><tr><td><table class="table"><colgroup><col style="width:4.42em"/><col style="width:11.67em"/><col style="width:3.77em"/><col style="width:7.12em"/></colgroup><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left">Group </td><td class="align_center">The tumor volume (mm<sup>3</sup>)</td><td class="align_center"><i>P</i></td><td class="align_center">Inhibitory rate</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">Control</td><td class="align_center">115.5 ± 20.2</td><td class="align_center" rowspan="2">&lt; 0.05</td><td class="align_center" rowspan="2">36.2%</td></tr><tr><td class="align_left">Test</td><td class="align_center">73.6 ± 14.3</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The tumor volume (means, n = 10) and inhibitory rate.</div>

BioMed Research International

tab2

Table 2

Table 2: Opening the Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble Contrast Agent 

Table 2 | Opening the Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble Contrast Agent 